Interax Biotech
1 known investors
InterAx uses its Deep Signal platform — combining mathematical modeling of cellular processes, experimental methods, and machine learning — to analyze GPCR cell signaling and design small-molecule drug candidates. The company applies this approach to understand disease impact early in drug discovery, aiming for candidates with higher efficacy and lower clinical failure rates.
Investors · 1
.jpeg){kind=logo}
Frequently asked questions
- What does Interax Biotech do?
- InterAx uses its Deep Signal platform — combining mathematical modeling of cellular processes, experimental methods, and machine learning — to analyze GPCR cell signaling and design small-molecule drug candidates. The company applies this approach to understand disease impact early in drug discovery, aiming for candidates with higher efficacy and lower clinical failure rates.
- Who are Interax Biotech's investors?
- Interax Biotech's investors include Verve Ventures.